Complete Genomics to Offer Ingenuity Variant Analysis with Whole-Genome Sequencing Service | GenomeWeb

Complete Genomics said this week that it will offer customers of its research whole-genome sequencing service access to Ingenuity's variant analysis capabilities.

Complete Genomics said that all orders for new research genomes will now include access to Ingenuity Variant Analysis for six months. The bundled offering will provide customers with a complete workflow to analyze, interpret, and prioritize biologically relevant genetic variations, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.